BRIDGEBIO PHARMA INC (BBIO)

US10806X1028 - Common Stock

24.95  -0.03 (-0.12%)

After market: 24.95 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
9.30M77.65M69.72M8.25M40.56M
Minority Interest Expense
10.05M3.47M23.92M56.76M28.00M
Cost Of Goods
N/A3.43M3.11M0.002.50M
Gross Profit
N/A74.21M66.60M8.25M38.06M
Operating Expenses
608.75M542.65M643.24M482.73M302.30M
Research and Development
458.16M399.46M451.02M337.05M207.95M
Selling, General, and Administrative Expenses
150.59M143.19M192.21M145.68M94.35M
Operating Income
-599.44M-468.43M-576.63M-474.48M-264.24M
Interest Income/Expense
-63.25M35.05M-45.65M-32.64M-20.72M
Other Income/Expense
17.37M-7.50M35.82M1.63M-1.21M
Non Recurring Items
-7.93M-43.77MN/AN/A-2.42M
Income Before Taxes
-653.25M-484.65M-586.45M-505.49M-288.59M
Net Income
-643.20M-481.18M-562.54M-448.72M-260.59M
EBITDA
-592.95M-461.66M-570.79MN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-3.95-3.26-3.90-3.80-2.48
Non GAAP EPS
-3.94-3.11-3.91-3.80N/A
 
Statistics
Gross Profit Margin
N/A95.57%95.52%100.00%93.84%
Profit Margin
-6913.92%-619.68%-806.86%-5439.03%-642.48%
Operating Profit Margin
-6443.56%-603.26%-827.07%-5751.27%-651.48%

All data in USD

Charts